How can erythropoietin requirements be reduced in dialysis patients?

Semin Dial. Sep-Oct 2006;19(5):363-72. doi: 10.1111/j.1525-139X.2006.00188.x.
No abstract available

MeSH terms

  • Arteriovenous Shunt, Surgical / adverse effects
  • Ascorbic Acid / therapeutic use
  • Carnitine / therapeutic use
  • Catheters, Indwelling / adverse effects
  • Cytokines / antagonists & inhibitors
  • Cytokines / physiology
  • Dialysis Solutions / adverse effects
  • Dialysis Solutions / standards
  • Dose-Response Relationship, Drug
  • Drug Contamination
  • Erythropoietin / administration & dosage*
  • Humans
  • Inflammation / etiology
  • Inflammation / prevention & control
  • Infusions, Intravenous
  • Iron / therapeutic use
  • Recombinant Proteins
  • Renal Dialysis*
  • Vitamin B Complex / therapeutic use
  • Vitamins / therapeutic use
  • Water Purification / standards

Substances

  • Cytokines
  • Dialysis Solutions
  • Recombinant Proteins
  • Vitamins
  • Erythropoietin
  • Vitamin B Complex
  • Iron
  • Ascorbic Acid
  • Carnitine